Example of how patients are managed based on risk estimates (using a common low-grade screening abnormality, HPV-positive ASC-US)
The initial screening result would lead to colposcopy (immediate risk 4.2%). Colposcopy of less than CIN 2 has a 5-year risk of 3.2% (1-year return). At the 1-year return visit, a second HPV-positive ASC-US result has an immediate risk of 3.1% (1-year return). If the patient has a repeat abnormal screen at the next follow-up, colposcopy is recommended. If the HPV-based test is negative, return in 3 years is recommended. NA, not applicable because stable risk estimates are not available.
From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI:
10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
